Le Lézard
Classified in: Health, Science and technology
Subject: CALENDAR OF EVENTS

IMV Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference


DARTMOUTH, Nova Scotia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Chief Executive Officer Frederic Ors and Chief Financial Officer Pierre Labbé will present a corporate update at the Annual Piper Jaffray Healthcare Conference, which takes place from November 27?29 in New York, NY.

IMV's presentation details include:

The webcast will be archived for 90 days following the live presentation. A copy of the presentation will also be available on the Events, Webcasts & Presentations page of IMV's website: www.imv-inc.com.

About IMV

IMV Inc., formerly Immunovaccine Inc., is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company's proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV's lead candidate, DPX-Survivac, is a T cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently assessing DPX-Survivac as a combination therapy in multiple clinical studies with Incyte and Merck. Connect at www.imv-inc.com.

Contacts for IMV:
MEDIA 
Mike Beyer, Sam Brown Inc.
T: (312) 961-2502 E: [email protected]

INVESTOR RELATIONS
Pierre Labbé, Chief Financial Officer
T: (902) 492-1819 E: [email protected]   

Patti Bank, Managing Director, Westwicke Partners
O: (415) 513-1284
T: (415) 515-4572 E: [email protected]


These press releases may also interest you

at 13:15
Biz Apps Partner Summit for Microsoft Ecosystem to Deliver FY 25 Insights
Dynamics Communities and Community Summit North America, in collaboration with Microsoft, are introducing the Biz Apps Partner Summit to run July 24-25, 2024, in Bellevue, Washington delivering a 24-hour immersion into FY 25 priorities, opportunities...

at 13:13
E-Textile Market Size to Grow USD 5238.3 Million by 2029 at a CAGR of 8% | Valuates Reports
E-Textile Market is Segmented by Type (Passive Electronic Textiles, Active Electronic Textiles, Ultra-Electronic Textiles), by Application (Military Uses, Civil Uses, Healthcare Uses). The Global E-Textile Market size is expected to reach USD 5238.3...

at 13:05
Dr. J. Mark Tuthill Joins Gestalt Diagnostics' Strategic Advisory Board
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

at 12:57
Hinkal Closes Strategic Funding Round to Advance Discreet Trading and Position Liquidation
Hinkal, a multi-chain privacy layer for confidential decentralized finance (DeFi) transactions, today announced a $1.4 million strategic funding round led by SALT Fund, with participation from Draper Associates, SNZ and Peer VC. Additionally, Tal...

at 12:45
Sogolytics Study Examines Patient Experience Gaps in Telehealth Adoption
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:39
Interfuse Adds New Features to its Knowledge Base
In an effort to provide the best service possible, enterprise developer Interfuse, has added several important improvements to its Knowledge Base application. Within this update, new pages accessible in the Knowledge Base include Recently Added,...

More news about Science and technology...


News published on and distributed by: